NeurAxis, Inc.

US$6.24As of Sun 8 Nov 2026, 12:00 UTC
AMEX:NRXSHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR 12.71%
Div yield —
ROE (139.76%)
Biotechnology
Beta (5Y) 1.38
PE TTM —
TSR TTM 129.41%
Mkt cap US$78.36M
ROIC (82.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.97
11.71%
(37.04%)
Hold 10|2|11|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.10
0.10
0.10
21.36%
21.99%
19.51%
23.05%
Revenue$M
5.183
5.490
5.560
5.504
14.34%
16.43%
12.25%
5.08%
Peers (US$78.36M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
6.603
(0.525)
(0.357)
EBIT/Intx
0.319
0.120
0.095
Own earn%
62.33
28.10
25.84
Sh yield%
22.25
55.99
54.72
Owners
Insiders/Inst%
10.14
72.72
Short interest%
5.80
SBC / revenue%
3.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
8–16
$1 testx
0.8
Incr. ROIC%
2